Skip to content

Rémi Rosière

  • PharmD, PhD
  • Spin-off developer (InhaTarget)
  • Universite Libre de Bruxelles Faculte de Pharmacie
  • 8h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 249CitationsNumber of citations received by Rémi's publications. Updated daily.

About

recently obtained a PhD degree by ULB for research completed in the Laboratory of Pharmaceutics and Biopharmaceutics under the supervision of Prof K. Amighi and Dr N. Wauthoz. I am currently working on the launch of a new spin-off company (InhaTarget) in the field of lung cancer targeted therapy.

Recent publications

  • Nanomedicine-Based Inhalation Treatments for Lung Cancer

    • Rosière R
    • Amighi K
    • Wauthoz N
    N/AReaders
    N/ACitations
    Get full text
  • The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses

    • Rosière R
    • Berghmans T
    • De Vuyst P
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Spin-off developer (InhaTarget)

Universite Libre de Bruxelles Faculte de Pharmacie

May 2016 - Present

PhD Student

Universite Libre de Bruxelles Faculte de Pharmacie

October 2010 - April 2016(6 years)

Education

FR2B

HEC-ULg Ecole de Gestion de l'Universite de Liege

January 2017

PhD

Universite Libre de Bruxelles Faculte de Pharmacie

January 2010 - January 2016(6 years)

FSTAL

Universite Libre de Bruxelles Faculte de Medecine

January 2011

Master degree

Universite Libre de Bruxelles Faculte de Pharmacie

January 2005 - January 2010(5 years)

Co-authors (42)

  • mickael marloye
  • Sharuk khan
  • Nathalie Wauthoz